Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Endurant Stent Graft System vs Excluder Endoprothesis: A Global, Prospective, Randomized Clinical Trial in Sac Regression
Medtronic Cardiovascular
600 participants
Jan 5, 2023
INTERVENTIONAL
Conditions
Summary
The purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems verses Gore Excluder / Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysms. Subjects are randomized and imaging collected at all follow-up time points to assess the primary endpoint.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
EVAR treatment with Medtronic Endurant II/IIs Stent Graft System
EVAR treatment with Excluder / Excluder Conformable Stent Graft System
Locations(68)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05378347